Article Text
Abstract
Healthcare policies developed during the COVID-19 pandemic to safeguard community health have the potential to disadvantage women in three areas. First, protocols for deferral of elective surgery may assign a lower priority to important reproductive outcomes. Second, policies regarding the prevention and treatment of COVID-19 may not capture the complexity of the considerations related to pregnancy. Third, policies formulated to reduce infectious exposure inadvertently may increase disparities in maternal health outcomes and rates of violence towards women. In this commentary, we outline these challenges unique to women’s healthcare in a pandemic, provide preliminary recommendations and identify areas for further exploration and refinement of policy.
- applied and professional ethics
- clinical ethics
- distributive justice
- obstetrics and gynaecology
- reproductive medicine
This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.
https://bmj.com/coronavirus/usageStatistics from Altmetric.com
Footnotes
Twitter @BethanyABruno, @KavitaShahArora
Contributors BB and KSA conceived of the manuscript. BB, DIS and KSA conducted the normative ethical analysis. BB took the lead in writing the manuscript. DIS and KSA revised the manuscript. KSA supervised the project. All authors have approved of the final version submitted.
Funding KSA is funded by the Clinical and Translational Science Collaborative of Cleveland, KL2TR0002547 from the National Center for Advancing Translational Sciences (NCATS) component of the National Institutes of Health and NIH roadmap for Medical Research.
Disclaimer This manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
Competing interests None declared.
Patient consent for publication Not required.
Provenance and peer review Not commissioned; externally peer reviewed.
Data availability statement There is no data in this work.
Read the full text or download the PDF:
Other content recommended for you
- Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis
- Global variations in the burden of SARS-CoV-2 infection and its outcomes in pregnant women by geographical region and country’s income status: a meta-analysis
- Multilevel determinants of racial/ethnic disparities in severe maternal morbidity and mortality in the context of the COVID-19 pandemic in the USA: protocol for a concurrent triangulation, mixed-methods study
- Association between the COVID-19 pandemic and the risk for adverse pregnancy outcomes: a cohort study
- Experience and impact of gender-based violence in Honiara, Solomon Islands: a cross-sectional study recording violence over a 12-month period
- COVID-19 in Pregnancy and Early Childhood (COPE): study protocol for a prospective, multicentre biobank, survey and database cohort study
- COVID-19 in Pregnancy in Scotland (COPS): protocol for an observational study using linked Scottish national data
- Risk factors of COVID-19 vertical transmission among pregnant and non-pregnant Filipinos in Metro Manila: a multicentre cohort study protocol
- Mental health of pregnant and postpartum women during the third wave of the COVID-19 pandemic: a European cross-sectional study
- Casualties of the World War II metaphor: women’s reproductive health fighting for narrative inclusion in COVID-19